Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Ceptaris

    - PMLiVE

    Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023

    The Medscape Education team will be on site at the 2023 EHA conference in Frankfurt, Germany to share the outcomes of recent hematology education programs and to advance the discussion on...

    Medscape Education

    Medscape Oncology: Delivering Impact at ASH

    You can read more information on Medscape Oncology at ASH here, or please reach out to Chris Carey or Steve Dunn who can tell you more about how Medscape can help to...

    Medscape Education

    Biogen Idec building

    Biogen and Genentech sign royalty agreement for blood cancer drug glofitamab

    Genentech will have sole decision-making rights on glofitamab's commercialisation in the US

    - PMLiVE

    Novartis’ iptacopan shows promise as rare blood disease treatment in phase 3 study

    Around 82.3% of patients achieved haemoglobin-level increases of 2g/dL or more from baseline

    - PMLiVE

    Pfizer shares updated pivotal phase 2 elranatamab data for multiple myeloma

    There are 176,000 new cases of the disease worldwide for which there is currently no cure

    - PMLiVE

    Lab-grown red blood cells used for human transfusions in world-first clinical trial

    Manufactured blood cells could revolutionise treatments for people with blood disorders

    - PMLiVE

    BMS’s Reblozyl meets primary endpoint in myelodysplastic syndromes phase 3 trial

    The study showed significant improvements in red blood cell transfusion independence

    - PMLiVE

    Novartis’ iptacopan shows promise as rare blood disease treatment in phase 3 study

    One to two people per million are diagnosed with paroxysmal nocturnal haemoglobinuria each year

    - PMLiVE

    Abstract Highlights from EHA 2022 : A Spotlight on CLL

    Spotlight on CLLAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in...

    Medscape Education

    - PMLiVE

    It’s a Medscape wrap for EHA2022

    EHA2022 Hybrid Congress has now come to a close with the Thematic Days finishing last week. The Medscape team were delighted to connect with so many physicians, colleagues and supporters...

    Medscape Education

    Part 4 of 4, of the Medscape video interview series

    Dr. Hansa Bhargava MD interviews Dr. Maria Victoria Mateos on the most important abstracts to look out for in multiple myeloma and the potential implications of these data for managing patients...

    Medscape Education

    - PMLiVE

    Mysterious big pharma company eyes US biotech Acceleron

    Speculation is running high that a major pharma company will make a move on Massachusetts-based pulmonary and haematology biotech Acceleron this week

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links